Literature DB >> 19936650

Post-treatment fulminant hepatic failure in an infant with Visceral leishmaniasis: Immune injury or stibogluconate toxicity?

Arun K Baranwal, Ravi N M Ravi, Rupa Singh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19936650     DOI： 10.1007/s12098-009-0265-0

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  5 in total

1.  Fulminant hepatitis in Kala-azar.

Authors:  U K Singh; R K Sinha; V K Sharma
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

2.  Fulminant hepatitis in an Italian infant with visceral leishmaniasis.

Authors:  L di Martino; P Vajro; A Nocerino; S Scotti; G Napolitano; A Vegnente
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Jan-Feb       Impact factor: 2.184

3.  Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.

Authors:  E M Carvalho; R S Teixeira; W D Johnson
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

4.  Hepatotoxicity of sodium stibogluconate therapy for American cutaneous leishmaniasis.

Authors:  N C Hepburn; I Siddique; A F Howie; G J Beckett; P C Hayes
Journal:  Trans R Soc Trop Med Hyg       Date:  1994 Jul-Aug       Impact factor: 2.184

5.  Liver morphology and function in visceral leishmaniasis (Kala-azar).

Authors:  I A el Hag; F A Hashim; I A el Toum; M Homeida; M el Kalifa; A M el Hassan
Journal:  J Clin Pathol       Date:  1994-06       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.